Indicus Pharma is a US based pharmaceutical company, registered in the State of Delaware and headquartered in Raleigh, North Carolina. The company is focused on the development and manufacture of niche generic formulations for the US market. Niche generics are technically challenging products with limited competition in the US Generic market and generally fetch greater market share with higher returns. These products are developed using specialized technologies that can be patented. Indicus Pharma is incorporated as a strategic alliance between USV Limited, India and Dr. Nitin Sheth (President & CEO: Indicus Pharma) with the goal of capitalizing on the opportunity in the US generic industry. Our strong marketing alliance and flexible business arrangement policies help us to create long-term, reliable partners. With a full development of products suggested by our clients, we also undertake new molecule development as well as engage in co-development practices.
| Website | http://www.indicuspharma.com |
| Revenue | $5.4 million |
| Employees | View employees |
| Address | 12308 Richmond Run Dr, Raleigh, North Carolina 27614, US |
| Phone | (919) 608-9981 |
| Fax | (919) 562-0224 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Teva Pharmaceuticals, Piramal Group, Abbott, SUN PHARMA, Cipla, Dr. Reddy's Laboratories, Aurobindo Pharma, Lupin Limited, Mylan Belgium, Zydus Cadila Healthcare Limited +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Indicus Pharma employee's phone or email?
Indicus Pharma Questions
The Indicus Pharma annual revenue was $5.4 million in 2026.
Indicus Pharma is based in Raleigh, North Carolina.
The NAICS codes for Indicus Pharma are [3254, 32541, 32, 325].
The SIC codes for Indicus Pharma are [283, 28].
